Acceptability of Intanza® 15 μg intradermal influenza vaccine in Belgium during the 2010–2011 influenza season
- 127 Downloads
Intradermal (ID) influenza vaccination induces an enhanced immune response in the elderly when compared with intramuscular (IM) vaccination. In 2009, an ID seasonal influenza vaccine (Intanza® [Sanofi Pasteur MSD, Lyon, France] 15 μg) was approved for use in individuals aged ≥ 60 years in Europe. This survey conducted in Belgium was the first in Europe to assess the acceptability of this vaccine in routine clinical practice by vaccinees and their general practitioners (GPs).
GPs willing to use both the ID and IM influenza vaccines were selected during the 2010–2011 influenza season. Each GP recruited ≤ 10 patients aged ≥ 60 years who received the ID vaccine. Vaccinees and GPs completed questionnaires about their opinions on influenza vaccination and the acceptability of the ID influenza vaccine.
In total, 105 GPs and 837 vaccinees completed questionnaires. A high proportion of vaccinees (40.3%) was aged ≥ 75 years, and 95.5% had been vaccinated the previous year. The majority of vaccinees was very satisfied (70.0%) or satisfied (27.9%) with the ID vaccine. The main reasons for the high satisfaction rate were that the injection was not very painful, administration was quick, and the vaccinee felt confident about the micro-needle injection system. Most vaccinees (91.1%) who had previously received IM influenza vaccination preferred the ID vaccine, and 98.5% of vaccinees reported they would consider receiving the ID vaccine the following year. The majority of GPs was very satisfied (78.6%) or satisfied (18.4%) with the ID vaccine, and most GPs (87.6%) expressed a preference for the ID vaccine over IM influenza vaccine.
The ID influenza vaccine was well accepted by vaccinees and their GPs, who expressed a preference for the ID vaccine over conventional IM influenza vaccine. The availability of the ID influenza vaccine may help to improve uptake of seasonal influenza vaccination in the elderly.
KeywordsBelgium Elderly individuals General practitioners Immunosenescence Intanza Intradermal influenza vaccine Micro-needle injection system Survey Vaccination acceptability
Unable to display preview. Download preview PDF.
- 1.World Health Organization. Influenza vaccines. Wkly Epidemiol Rec. 2005;80:279–287.Google Scholar
- 2.World Health Organization. Fifty-sixth World Health Assembly (WHA). Prevention and control of influenza pandemics and annual epidemics. WHA 10th plenary meeting, 28 May 2003. Available at: apps.who.int/gb/archive/pdf_files/WHA56/ea56r19.pdf. Accessed Jan 5 2012.
- 3.Council of the European Union. Council recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/EU). Off J Eur Union. 2009;348:71–72. Available at: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF. Accessed Jan 5 2012.Google Scholar
- 4.Superior Health Council. Publication of the Superior Health Council No. 8682, September 1, 2010. Vaccination against seasonal influenza. Winter Season 2010–2011. [Article in French]. Available at: http://www.health.belgium.be/internet2Prd/groups/public/@public/@shc/documents/ie2divers/19064111_fr.pdf. Accessed May 21 2012.
- 10.Mereckiene J, Cotter S, D’Ancona F, et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008–2009. Euro Surveill. 2010;15.pii:19700.Google Scholar
- 14.Castilla J, Moran J, Martinez-Artola V, et al. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis. Euro Surveill. 2011;16.pii:19799.Google Scholar
- 18.European Commission. Commission decision of 24.2.2009 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for “INTANZA — Influenza Vaccine (split virion, inactivated)”, a medicinal product for human use. Available at: http://ec.europa.eu/health/documents/communityregister/2009/2009022454169/dec_54169_en.pdf. Accessed Jan 5 2012.
- 26.Organisation for Economic Co-operation and Development (OECD). OECD Health Data 2011. Health care activities — vaccination rates against influenza for people 65 and over. Available from: http://www.oecd.org/document/16/0,3746,en_2649_37407_2085200_1_1_1_37407,00.html. Accessed Jan 5 2012.